✦ LIBER ✦

Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors

✍ Scribed by Maria Luisa Veronese; Keith Flaherty; Amy Kramer; Barbara A. Konkle; Mark Morgan; James P. Stevenson; Peter J. O’Dwyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tesetaxel, a new oral taxane, in combina

✍ Muhammad Wasif Saif; John Sarantopoulos; Amita Patnaik; Anthony W. Tolcher; Chri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

Phase I dose escalation study of KOS-158

✍ Elaine T. Lam; Sanjay Goel; Larry J. Schaaf; Gillian F. Cropp; Alison L. Hannah; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 280 KB

A Phase I study of bortezomib plus irino

✍ David P. Ryan; Bert H. O'Neil; Jeffrey G. Supko; Carlo M. Rocha Lima; E. Claire 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Phase I study of cetuximab, erlotinib, a

✍ Chia-Chi Lin; Emiliano Calvo; Kyriakos P. Papadopoulos; Amita Patnaik; John Sara 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 278 KB

A phase I pharmacokinetics study of 9-ni

✍ Zhao Yan; Zhongling Zhu; Kai Li; Peng Chen; Liuchun Wang; Chun Huang; Jinhuai Xu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 209 KB

A phase I study of bortezomib and temozo

✍ J. Portnow; P. Frankel; S. Koehler; P. Twardowski; S. Shibata; C. Martel; R. Mor 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 384 KB